PMID: 2111137Jan 1, 1990Paper

New aspects of blood component therapy

Anaesthesiologie und Reanimation
C DettmannK Wilms

Abstract

The medical demand for factor VIII is increasing through continuously improved therapy of patients suffering from haemophilia A. The most important raw material for the production of factor VIII is fresh frozen plasma (FFP). Its clinical usage increased in the last few years dramatically. An alternative to FFP is the high grade blood component cryo-poor plasma (CPP). CPP is characterized by a deficiency of factor VIII and fibrinogen which is not of clinical relevance. It can be used instead of FFP in 95% of cases. Thus, FFP is more available for the production of factor VIII and the supply of factor VIII for haemophiliacs will improve.

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Beiträge zur Infusionstherapie = Contributions to infusion therapy
J Roewer, C Dettmann
La Revue du praticien
Y Laurian
JPMA. the Journal of the Pakistan Medical Association
Bushra MoizKhalid Zafar Hashmi
© 2021 Meta ULC. All rights reserved